Egypt vs North Macedonia: Access to anti-retroviral drugs, female
Egypt
46.0%
in 2024
North Macedonia
49.0%
in 2024
Egypt rank
125th
North Macedonia rank
123rd
Access to anti-retroviral drugs, female over time
- Egypt
- North Macedonia
How they compare
North Macedonia currently reports 49.0% against 46.0% in Egypt, a difference of 3.0%.
That makes North Macedonia's figure about 1.1 times Egypt's.
Across all 25 years both countries report, North Macedonia has been ahead every year.
Egypt ranks 125th and North Macedonia ranks 123rd of 141 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 21.2% | 21.1% | North Macedonia |
| 2010s | 14.0% | 45.3% | 31.3% | North Macedonia |
| 2020s | 36.8% | 46.2% | 9.4% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Egypt or North Macedonia?
- North Macedonia, at 49.0% against 46.0% in Egypt as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Egypt and North Macedonia?
- 3.0%, with North Macedonia ahead.
- How many years of comparable data are there for Egypt and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and North Macedonia rank globally for access to anti-retroviral drugs, female?
- Egypt ranks 125th and North Macedonia ranks 123rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.